Where's it on?
FDA · Drugs ·

fentaNYL Citrate Injectable Solution recall

Wells Pharma of Houston LLC recalled fentaNYL Citrate Injectable Solution on May 6, 2026 because of cGMP deviations. It was sold nationwide.

Why it was recalled

cGMP deviations.

What's recalled

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.

Quantity: 50 syringes

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice